These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


634 related items for PubMed ID: 19704105

  • 1. Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation.
    Kudo H, Kai H, Kajimoto H, Koga M, Takayama N, Mori T, Ikeda A, Yasuoka S, Anegawa T, Mifune H, Kato S, Hirooka Y, Imaizumi T.
    Hypertension; 2009 Oct; 54(4):832-8. PubMed ID: 19704105
    [Abstract] [Full Text] [Related]

  • 2. Large blood pressure variability and hypertensive cardiac remodeling--role of cardiac inflammation.
    Kai H, Kudo H, Takayama N, Yasuoka S, Kajimoto H, Imaizumi T.
    Circ J; 2009 Dec; 73(12):2198-203. PubMed ID: 19875896
    [Abstract] [Full Text] [Related]

  • 3. Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats.
    Yasuoka S, Kai H, Kajimoto H, Kudo H, Takayama N, Anegawa T, Koga M, Miyamoto T, Mifune H, Kage M, Hirooka Y, Imaizumi T.
    Circ J; 2013 Dec; 77(6):1474-81. PubMed ID: 23470864
    [Abstract] [Full Text] [Related]

  • 4. Simvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways.
    Takayama N, Kai H, Kudo H, Yasuoka S, Mori T, Anegawa T, Koga M, Kajimoto H, Hirooka Y, Imaizumi T.
    Hypertens Res; 2011 Mar; 34(3):341-7. PubMed ID: 21124329
    [Abstract] [Full Text] [Related]

  • 5. Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II.
    Kai H, Mori T, Tokuda K, Takayama N, Tahara N, Takemiya K, Kudo H, Sugi Y, Fukui D, Yasukawa H, Kuwahara F, Imaizumi T.
    Hypertens Res; 2006 Sep; 29(9):711-8. PubMed ID: 17249527
    [Abstract] [Full Text] [Related]

  • 6. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis.
    Tokuda K, Kai H, Kuwahara F, Yasukawa H, Tahara N, Kudo H, Takemiya K, Koga M, Yamamoto T, Imaizumi T.
    Hypertension; 2004 Feb; 43(2):499-503. PubMed ID: 14699000
    [Abstract] [Full Text] [Related]

  • 7. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
    Zhao Y, Ma R, Yu X, Li N, Zhao X, Yu J.
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
    [Abstract] [Full Text] [Related]

  • 8. Large blood pressure variability aggravates arteriolosclerosis and cortical sclerotic changes in the kidney in hypertensive rats.
    Aoki Y, Kai H, Kajimoto H, Kudo H, Takayama N, Yasuoka S, Anegawa T, Iwamoto Y, Uchiwa H, Fukuda K, Kage M, Kato S, Fukumoto Y, Imaizumi T.
    Circ J; 2014 Sep; 78(9):2284-91. PubMed ID: 24976508
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sub-depressor dose of angiotensin type-1 receptor blocker inhibits transforming growth factor-beta-mediated perivascular fibrosis in hypertensive rat hearts.
    Tokuda K, Kai H, Kuwahara F, Imaizumi T.
    J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S61-5. PubMed ID: 14871031
    [Abstract] [Full Text] [Related]

  • 11. NADPH oxidase contributes to the left ventricular dysfunction induced by sinoaortic denervation in rats.
    Zhang L, Li F, Zhi G, Zhang B, Chen YD.
    Free Radic Res; 2015 Jan; 49(1):57-66. PubMed ID: 25356862
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H, Minamino T, Tsukamoto O, Kim J, Okada K, Myoishi M, Wakeno M, Takashima S, Mochizuki N, Kitakaze M.
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [Abstract] [Full Text] [Related]

  • 13. Effect of farnesyltransferase inhibition on cardiac remodeling in spontaneously hypertensive rats.
    Li X, Han J, Li L, Wang KJ, Hu SJ.
    Int J Cardiol; 2013 Oct 09; 168(4):3340-7. PubMed ID: 23664044
    [Abstract] [Full Text] [Related]

  • 14. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
    Wang WW, Zhang FL, Chen JH, Chen XH, Fu FY, Tang MR, Chen LL.
    Can J Physiol Pharmacol; 2015 Aug 09; 93(8):657-65. PubMed ID: 26158699
    [Abstract] [Full Text] [Related]

  • 15. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH, Chang YS.
    Nephrol Dial Transplant; 2010 Feb 09; 25(2):389-99. PubMed ID: 19749146
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
    Jones ES, Black MJ, Widdop RE.
    J Mol Cell Cardiol; 2004 Nov 09; 37(5):1023-30. PubMed ID: 15522279
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
    Nishio M, Sakata Y, Mano T, Yoshida J, Ohtani T, Takeda Y, Miwa T, Masuyama T, Yamamoto K, Hori M.
    J Hypertens; 2007 Feb 09; 25(2):455-61. PubMed ID: 17211254
    [Abstract] [Full Text] [Related]

  • 19. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M.
    Am J Hypertens; 2007 Oct 09; 20(10):1119-24. PubMed ID: 17903697
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.